On-Demand Webcast

Share

Program Content

Activities

  • Advances in Relapsed/Refractory Multiple Myeloma
    New Advances in Relapsed/Refractory Multiple Myeloma: Current Guidance and Future Perspectives
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 14, 2020

    Expires: September 13, 2021

Provided by

ProCE Banner

Supporters

GlaxoSmithKline LLC

Sanofi Genzyme Corp